ENTEROPharmacy Retail
Entero Healthcare Solutions — Profit & Loss Statement
₹1247.80
+0.05%
Entero Healthcare Solutions Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -1.61 Cr | -1.88 Cr | — |
| Tax Rate For Calcs | 0.23 | 0.30 | 0.30 | 0.30 | — |
| Normalized EBITDA | 211.05 Cr | 126.26 Cr | 70.33 Cr | 32.29 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 94.82 Cr | 39.11 Cr | -11.56 Cr | -29.92 Cr | — |
| Reconciled Depreciation | 30.69 Cr | 25.02 Cr | 24.24 Cr | 19.75 Cr | — |
| Reconciled Cost Of Revenue | 4.61K Cr | 3.57K Cr | 3.03K Cr | 2.31K Cr | — |
| EBITDA | 211.05 Cr | 126.26 Cr | 64.95 Cr | 26.04 Cr | — |
| EBIT | 180.36 Cr | 101.24 Cr | 40.71 Cr | 6.28 Cr | — |
| Net Interest Income | -41.62 Cr | -65.68 Cr | -44.88 Cr | -25.54 Cr | — |
| Interest Expense | 41.62 Cr | 65.68 Cr | 44.40 Cr | 26.09 Cr | — |
| Normalized Income | 94.82 Cr | 39.11 Cr | -7.79 Cr | -25.55 Cr | — |
| Net Income From Continuing And Discontinued Operation | 94.82 Cr | 39.11 Cr | -11.56 Cr | -29.92 Cr | — |
| Total Expenses | 4.95K Cr | 3.84K Cr | 3.25K Cr | 2.50K Cr | — |
| Diluted Average Shares | 4.36 Cr | 3.62 Cr | 4.35 Cr | 4.35 Cr | — |
| Basic Average Shares | 4.35 Cr | 3.62 Cr | 4.35 Cr | 4.35 Cr | — |
| Diluted EPS | 21.76 | 10.81 | -2.66 | -6.88 | — |
| Basic EPS | 21.80 | 10.81 | -2.66 | -6.88 | — |
| Diluted NI Availto Com Stockholders | 94.82 Cr | 39.11 Cr | -11.56 Cr | -29.92 Cr | — |
| Net Income Common Stockholders | 94.82 Cr | 39.11 Cr | -11.56 Cr | -29.92 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 94.82 Cr | 39.11 Cr | -11.56 Cr | -29.92 Cr | — |
| Minority Interests | -12.61 Cr | -0.69 Cr | -0.45 Cr | -0.48 Cr | — |
| Net Income Including Noncontrolling Interests | 107.43 Cr | 39.80 Cr | -11.10 Cr | -29.44 Cr | — |
| Net Income Continuous Operations | 107.43 Cr | 39.80 Cr | -11.10 Cr | -29.44 Cr | — |
| Tax Provision | 31.30 Cr | -4.24 Cr | 7.42 Cr | 9.63 Cr | — |
| Pretax Income | 138.74 Cr | 35.55 Cr | -3.69 Cr | -19.81 Cr | — |
| Other Non Operating Income Expenses | 39.51 Cr | 14.41 Cr | 1.41 Cr | 0.89 Cr | — |
| Net Non Operating Interest Income Expense | -41.62 Cr | -65.68 Cr | -44.88 Cr | -25.54 Cr | — |
| Interest Expense Non Operating | 41.62 Cr | 65.68 Cr | 44.40 Cr | 26.09 Cr | — |
| Operating Income | 140.86 Cr | 86.83 Cr | 45.15 Cr | 10.93 Cr | — |
| Operating Expense | 345.45 Cr | 265.13 Cr | 216.13 Cr | 191.90 Cr | — |
| Other Operating Expenses | 115.72 Cr | 88.97 Cr | 31.05 Cr | 24.06 Cr | — |
| Depreciation And Amortization In Income Statement | 30.69 Cr | 25.02 Cr | 24.24 Cr | 19.75 Cr | — |
| Depreciation Income Statement | 30.69 Cr | 25.02 Cr | 23.58 Cr | 19.23 Cr | — |
| Gross Profit | 486.31 Cr | 351.96 Cr | 261.28 Cr | 202.83 Cr | — |
| Cost Of Revenue | 4.61K Cr | 3.57K Cr | 3.03K Cr | 2.31K Cr | — |
| Total Revenue | 5.10K Cr | 3.92K Cr | 3.29K Cr | 2.52K Cr | — |
| Operating Revenue | 5.10K Cr | 3.92K Cr | 3.29K Cr | 2.52K Cr | — |
| Total Unusual Items | — | -7.48 Cr | -5.38 Cr | -6.25 Cr | -1.41 Cr |
| Total Unusual Items Excluding Goodwill | — | -7.48 Cr | -5.38 Cr | -6.25 Cr | -1.41 Cr |
| Interest Income | — | 13.33 Cr | 4.09 Cr | 3.44 Cr | 2.94 Cr |
| Rent Expense Supplemental | — | 0.67 Cr | 1.67 Cr | 1.47 Cr | 1.96 Cr |
| Special Income Charges | — | -7.48 Cr | -5.38 Cr | -6.25 Cr | -1.41 Cr |
| Other Special Charges | — | -0.04 Cr | — | — | — |
| Write Off | — | 7.52 Cr | 5.38 Cr | 6.25 Cr | 1.41 Cr |
| Total Other Finance Cost | — | 5.20 Cr | 4.57 Cr | 2.88 Cr | 3.66 Cr |
| Interest Income Non Operating | — | 13.33 Cr | 4.09 Cr | 3.44 Cr | 2.94 Cr |
| Amortization | — | 0.42 Cr | 0.65 Cr | 0.52 Cr | 0.19 Cr |
| Selling General And Administration | — | 44.74 Cr | 38.10 Cr | 38.60 Cr | 22.36 Cr |
| Selling And Marketing Expense | — | 33.23 Cr | 27.29 Cr | 24.86 Cr | 13.22 Cr |
| General And Administrative Expense | — | 11.51 Cr | 10.81 Cr | 13.74 Cr | 9.14 Cr |
| Rent And Landing Fees | — | 0.67 Cr | 1.67 Cr | 1.47 Cr | 1.96 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Entero Healthcare Solutions
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.